Inhibition	NN	B-NP	O	Other	###	1	Inhibition	Inhibition	NN	NN	_	0	root	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	4	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	3	IL-17	IL-17	NN	NN	_	4	compound	_	_
production	NN	I-NP	O	Other	###	4	production	production	NN	NN	_	1	nmod	_	_
by	IN	B-PP	O	Other	###	5	by	by	IN	IN	_	8	case	_	_
signal	NN	B-NP	B-protein	Other	###	6	signal	signal	NN	NN	_	8	compound	_	_
transduction	NN	I-NP	I-protein	Other	###	7	transduction	transduction	NN	NN	_	8	compound	_	_
inhibitors	NNS	I-NP	I-protein	Other	###	8	inhibitors	inhibitors	NNS	NNS	_	1	nmod	_	_
and	CC	O	O	Other	###	9	and	and	CC	CC	_	8	cc	_	_
anti-rheumatic	JJ	B-NP	O	Other	###	10	anti-rheumatic	anti-rheumatic	JJ	JJ	_	11	amod	_	_
drugs	NNS	I-NP	O	Other	###	11	drugs	drugs	NNS	NNS	_	8	conj	_	_

Having	VBG	B-VP	O	Other	###	1	Having	Having	VBG	VBG	_	2	mark	_	_
observed	VBN	I-VP	O	Other	###	2	observed	observed	VBN	VBN	_	0	root	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	6	det	_	_
increased	VBN	I-NP	O	Other	###	4	increased	increased	VBN	VBN	_	6	amod	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	5	IL-17	IL-17	NN	NN	_	6	compound	_	_
production	NN	I-NP	O	Other	###	6	production	production	NN	NN	_	2	dobj	_	_
in	IN	B-PP	O	Other	###	7	in	in	IN	IN	_	9	case	_	_
RA	NN	B-NP	O	Other	###	8	RA	RA	NN	NN	_	9	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	9	PBMC	PBMC	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	13	punct	_	_
it	PRP	B-NP	O	Other	###	11	it	it	PRP	PRP	_	13	nsubj	_	_
was	VBD	B-VP	O	Other	###	12	was	was	VBD	VBD	_	13	cop	_	_
important	JJ	B-ADJP	O	Other	###	13	important	important	JJ	JJ	_	2	parataxis	_	_
to	TO	B-VP	O	Other	###	14	to	to	TO	TO	_	15	mark	_	_
know	VB	I-VP	O	Other	###	15	know	know	VB	VB	_	13	xcomp	_	_
which	WDT	B-NP	O	Other	###	16	which	which	WDT	WDT	_	19	det	_	_
signal	NN	I-NP	O	Other	###	17	signal	signal	NN	NN	_	19	compound	_	_
transduction	NN	I-NP	O	Other	###	18	transduction	transduction	NN	NN	_	19	compound	_	_
pathways	NNS	I-NP	O	Other	###	19	pathways	pathways	NNS	NNS	_	21	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	20	were	were	VBD	VBD	_	21	auxpass	_	_
involved	VBN	I-VP	O	Other	###	21	involved	involved	VBN	VBN	_	15	ccomp	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	13	punct	_	_

As	IN	B-SBAR	O	Other	###	1	As	As	IN	IN	_	2	mark	_	_
illustrated	VBN	B-VP	O	Other	###	2	illustrated	illustrated	VBN	VBN	_	18	advcl	_	_
in	IN	B-PP	O	Other	###	3	in	in	IN	IN	_	4	case	_	_
Fig	NNP	B-NP	O	Other	###	4	Fig	Fig	NNP	NNP	_	2	nmod	_	_
.	.	O	O	Other	###	5	.	.	.	.	_	4	punct	_	_
3	CD	I-NP	O	Other	###	6	3	3	CD	CD	_	4	nummod	_	_
,	,	O	O	Other	###	7	,	,	,	,	_	18	punct	_	_
an	DT	B-NP	O	Other	###	8	an	an	DT	DT	_	10	det	_	_
significant	JJ	I-NP	O	Other	###	9	significant	significant	JJ	JJ	_	10	amod	_	_
decrease	NN	I-NP	O	Other	###	10	decrease	decrease	NN	NN	_	18	nsubjpass	_	_
in	IN	B-PP	O	Other	###	11	in	in	IN	IN	_	16	case	_	_
anti-CD3	JJ	B-NP	O	Other	###	12	anti-CD3	anti-CD3	JJ	JJ	_	16	amod	_	_
-	-	O	O	Other	###	13	-	-	-	-	_	14	punct	_	_
induced	JJ	B-NP	O	Other	###	14	induced	induced	JJ	JJ	_	12	dep	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	15	IL-17	IL-17	NN	NN	_	16	compound	_	_
production	NN	I-NP	O	Other	###	16	production	production	NN	NN	_	10	nmod	_	_
was	VBD	B-VP	O	Other	###	17	was	was	VBD	VBD	_	18	auxpass	_	_
observed	VBN	I-VP	O	Other	###	18	observed	observed	VBN	VBN	_	0	root	_	_
when	WRB	B-ADVP	O	Other	###	19	when	when	WRB	WRB	_	20	advmod	_	_
co-incubated	VBN	B-VP	O	Other	###	20	co-incubated	co-incubated	VBN	VBN	_	18	advcl	_	_
with	IN	B-PP	O	Other	###	21	with	with	IN	IN	_	23	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	22	NF-kappaB	NF-kappaB	NN	NN	_	23	compound	_	_
inhibitor	NN	I-NP	O	Other	###	23	inhibitor	inhibitor	NN	NN	_	20	nmod	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	23	punct	_	_
PDTC	NN	B-NP	O	Other	###	25	PDTC	PDTC	NN	NN	_	23	conj	_	_
and	CC	I-NP	O	Other	###	26	and	and	CC	CC	_	25	cc	_	_
dexamethasone	NN	I-NP	O	Other	###	27	dexamethasone	dexamethasone	NN	NN	_	25	conj	_	_
in	IN	B-PP	O	Other	###	28	in	in	IN	IN	_	29	case	_	_
comparison	NN	B-NP	O	Other	###	29	comparison	comparison	NN	NN	_	18	nmod	_	_
with	IN	B-PP	O	Other	###	30	with	with	IN	IN	_	31	case	_	_
anti-CD3	NN	B-NP	B-protein	Other	###	31	anti-CD3	anti-CD3	NN	NN	_	29	nmod	_	_
alone	RB	B-ADVP	O	Other	###	32	alone	alone	RB	RB	_	31	advmod	_	_
(	(	O	O	Other	###	33	(	(	(	(	_	34	punct	_	_
38	CD	B-NP	O	Other	###	34	38	38	CD	CD	_	31	dep	_	_
+/-	CC	I-NP	O	Other	###	35	+/-	+/-	CC	CC	_	34	cc	_	_
5	CD	I-NP	O	Other	###	36	5	5	CD	CD	_	34	conj	_	_
and	CC	I-NP	O	Other	###	37	and	and	CC	CC	_	36	cc	_	_
54	CD	I-NP	O	Other	###	38	54	54	CD	CD	_	36	conj	_	_
+/-	SYM	I-NP	O	Other	###	39	+/-	+/-	SYM	SYM	_	38	cc	_	_
11	CD	I-NP	O	Other	###	40	11	11	CD	CD	_	38	conj	_	_
versus	IN	B-PP	O	Other	###	41	versus	versus	IN	IN	_	38	cc	_	_
98	CD	B-NP	O	Other	###	42	98	98	CD	CD	_	38	conj	_	_
+/-	SYM	I-NP	O	Other	###	43	+/-	+/-	SYM	SYM	_	42	cc	_	_
19	CD	I-NP	O	Other	###	44	19	19	CD	CD	_	42	conj	_	_
pg	NN	I-NP	O	Other	###	45	pg	pg	NN	NN	_	47	compound	_	_
/	/	O	O	Other	###	46	/	/	/	/	_	47	punct	_	_
ml	NN	I-NP	O	Other	###	47	ml	ml	NN	NN	_	34	dep	_	_
,	,	O	O	Other	###	48	,	,	,	,	_	47	punct	_	_
respectively	RB	B-ADVP	O	Other	###	49	respectively	respectively	RB	RB	_	47	advmod	_	_
;	:	O	O	Other	###	50	;	;	:	:	_	47	punct	_	_
P	NN	B-NP	O	Other	###	51	P	P	NN	NN	_	52	dep	_	_
<	SYM	B-NP	O	Other	###	52	<	<	SYM	SYM	_	47	dep	_	_
0.05	CD	I-NP	O	Other	###	53	0.05	0.05	CD	CD	_	52	nummod	_	_
)	)	O	O	Other	###	54	)	)	)	)	_	47	punct	_	_
.	.	O	O	Other	###	55	.	.	.	.	_	18	punct	_	_

LY294002	NN	B-NP	O	Other	###	1	LY294002	LY294002	NN	NN	_	13	nsubj	_	_
and	CC	I-NP	O	Other	###	2	and	and	CC	CC	_	1	cc	_	_
wortmannin	NN	I-NP	O	Other	###	3	wortmannin	wortmannin	NN	NN	_	1	conj	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	1	punct	_	_
as	IN	B-PP	O	Other	###	5	as	as	IN	IN	_	7	case	_	_
an	DT	B-NP	O	Other	###	6	an	an	DT	DT	_	7	det	_	_
inhibitor	NN	I-NP	O	Other	###	7	inhibitor	inhibitor	NN	NN	_	13	nmod	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
PI3K	NN	B-NP	B-protein	Other	###	9	PI3K	PI3K	NN	NN	_	7	nmod	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	13	punct	_	_
also	RB	B-ADVP	O	Other	###	11	also	also	RB	RB	_	13	advmod	_	_
markedly	RB	B-ADVP	O	Other	###	12	markedly	markedly	RB	RB	_	13	advmod	_	_
inhibited	VBD	B-VP	O	Other	###	13	inhibited	inhibited	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	14	the	the	DT	DT	_	19	det	_	_
anti-CD3	JJ	I-NP	O	Other	###	15	anti-CD3	anti-CD3	JJ	JJ	_	19	amod	_	_
-	-	O	O	Other	###	16	-	-	-	-	_	17	punct	_	_
induced	JJ	I-NP	O	Other	###	17	induced	induced	JJ	JJ	_	19	amod	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	18	IL-17	IL-17	NN	NN	_	19	compound	_	_
production	NN	I-NP	O	Other	###	19	production	production	NN	NN	_	13	dobj	_	_
in	IN	B-PP	O	Other	###	20	in	in	IN	IN	_	22	case	_	_
RA	NN	B-NP	O	Other	###	21	RA	RA	NN	NN	_	22	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	22	PBMC	PBMC	NN	NN	_	19	nmod	_	_
(	(	O	O	Other	###	23	(	(	(	(	_	34	punct	_	_
98	CD	B-NP	O	Other	###	24	98	98	CD	CD	_	34	nsubj	_	_
+/-	SYM	I-NP	O	Other	###	25	+/-	+/-	SYM	SYM	_	24	cc	_	_
19	CD	I-NP	O	Other	###	26	19	19	CD	CD	_	24	conj	_	_
versus	IN	B-PP	O	Other	###	27	versus	versus	IN	IN	_	26	cc	_	_
38	CD	B-NP	O	Other	###	28	38	38	CD	CD	_	26	conj	_	_
+/-	SYM	I-NP	O	Other	###	29	+/-	+/-	SYM	SYM	_	28	cc	_	_
10	CD	I-NP	O	Other	###	30	10	10	CD	CD	_	28	conj	_	_
pg	NN	I-NP	O	Other	###	31	pg	pg	NN	NN	_	24	dep	_	_
/	/	O	O	Other	###	32	/	/	/	/	_	33	punct	_	_
ml	NN	I-NP	O	Other	###	33	ml	ml	NN	NN	_	31	dep	_	_
[	(	O	O	Other	###	34	[	[	(	(	_	13	parataxis	_	_
P	NN	B-NP	O	Other	###	35	P	P	NN	NN	_	36	compound	_	_
<	SYM	B-NP	O	Other	###	36	<	<	SYM	SYM	_	34	dobj	_	_
0.005	CD	I-NP	O	Other	###	37	0.005	0.005	CD	CD	_	36	nummod	_	_
]	)	O	O	Other	###	38	]	]	)	)	_	34	dep	_	_
and	CC	O	O	Other	###	39	and	and	CC	CC	_	38	cc	_	_
48	CD	B-NP	O	Other	###	40	48	48	CD	CD	_	43	nummod	_	_
+/-	CC	I-NP	O	Other	###	41	+/-	+/-	CC	CC	_	40	cc	_	_
4	CD	I-NP	O	Other	###	42	4	4	CD	CD	_	40	conj	_	_
pg	NN	I-NP	O	Other	###	43	pg	pg	NN	NN	_	38	conj	_	_
/	/	O	O	Other	###	44	/	/	/	/	_	45	punct	_	_
ml	NN	I-NP	O	Other	###	45	ml	ml	NN	NN	_	43	dep	_	_
[	(	O	O	Other	###	46	[	[	(	(	_	45	amod	_	_
P	NN	B-NP	O	Other	###	47	P	P	NN	NN	_	48	compound	_	_
<	SYM	O	O	Other	###	48	<	<	SYM	SYM	_	46	dobj	_	_
0.05	CD	B-NP	O	Other	###	49	0.05	0.05	CD	CD	_	48	nummod	_	_
]	)	O	O	Other	###	50	]	]	)	)	_	46	dep	_	_
,	,	O	O	Other	###	51	,	,	,	,	_	46	punct	_	_
respectively	RB	B-ADVP	O	Other	###	52	respectively	respectively	RB	RB	_	46	advmod	_	_
)	)	O	O	Other	###	53	)	)	)	)	_	34	punct	_	_
.	.	O	O	Other	###	54	.	.	.	.	_	13	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	3	det	_	_
calcineurin	NN	I-NP	B-protein	B-Protein	###	2	calcineurin	calcineurin	NN	NN	_	3	compound	_	_
inhibitors	NNS	I-NP	O	Other	###	3	inhibitors	inhibitors	NNS	NNS	_	9	nsubj	_	_
cyclosporin	NN	I-NP	O	Other	###	4	cyclosporin	cyclosporin	NN	NN	_	5	compound	_	_
A	NN	I-NP	O	Other	###	5	A	A	NN	NN	_	3	dep	_	_
and	CC	O	O	Other	###	6	and	and	CC	CC	_	5	cc	_	_
FK506	NN	B-NP	O	Other	###	7	FK506	FK506	NN	NN	_	5	conj	_	_
also	RB	B-ADVP	O	Other	###	8	also	also	RB	RB	_	9	advmod	_	_
downregulated	VBD	B-VP	O	Other	###	9	downregulated	downregulated	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	10	the	the	DT	DT	_	12	det	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	11	IL-17	IL-17	NN	NN	_	12	compound	_	_
secretion	NN	I-NP	O	Other	###	12	secretion	secretion	NN	NN	_	9	dobj	_	_
as	RB	B-CONJP	O	Other	###	13	as	as	RB	RB	_	12	cc	_	_
well	RB	I-CONJP	O	Other	###	14	well	well	RB	RB	_	13	mwe	_	_
as	IN	I-CONJP	O	Other	###	15	as	as	IN	IN	_	13	mwe	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	27	det	_	_
mitogen	JJ	I-NP	B-protein	Other	###	17	mitogen	mitogen	JJ	JJ	_	27	amod	_	_
-	-	O	O	Other	###	18	-	-	-	-	_	27	punct	_	_
activated	JJ	I-NP	B-protein	Other	###	19	activated	activated	JJ	JJ	_	27	amod	_	_
protein	NN	I-NP	I-protein	Other	###	20	protein	protein	NN	NN	_	27	compound	_	_
kinase	NN	I-NP	I-protein	Other	###	21	kinase	kinase	NN	NN	_	27	compound	_	_
(	(	O	O	Other	###	22	(	(	(	(	_	27	punct	_	_
MAPK	NN	B-NP	B-protein	Other	###	23	MAPK	MAPK	NN	NN	_	27	compound	_	_
)	)	O	O	Other	###	24	)	)	)	)	_	27	punct	_	_
p38	NN	B-NP	O	Other	###	25	p38	p38	NN	NN	_	27	compound	_	_
inhibitor	NN	I-NP	O	Other	###	26	inhibitor	inhibitor	NN	NN	_	27	compound	_	_
SB203580	NN	I-NP	O	Other	###	27	SB203580	SB203580	NN	NN	_	12	conj	_	_
did	VBD	B-VP	O	Other	###	28	did	did	VBD	VBD	_	9	conj	_	_
,	,	O	O	Other	###	29	,	,	,	,	_	9	punct	_	_
whereas	IN	O	O	Other	###	30	whereas	whereas	IN	IN	_	34	mark	_	_
rapamycin	NN	B-NP	O	Other	###	31	rapamycin	rapamycin	NN	NN	_	34	nsubj	_	_
and	CC	I-NP	O	Other	###	32	and	and	CC	CC	_	31	cc	_	_
PD98059	NN	I-NP	O	Other	###	33	PD98059	PD98059	NN	NN	_	31	conj	_	_
had	VBD	B-VP	O	Other	###	34	had	had	VBD	VBD	_	9	parataxis	_	_
no	DT	B-NP	O	Other	###	35	no	no	DT	DT	_	36	neg	_	_
effect	NN	I-NP	O	Other	###	36	effect	effect	NN	NN	_	34	dobj	_	_
on	IN	B-PP	O	Other	###	37	on	on	IN	IN	_	39	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	38	IL-17	IL-17	NN	NN	_	39	compound	_	_
levels	NNS	I-NP	O	Other	###	39	levels	levels	NNS	NNS	_	34	nmod	_	_
(	(	O	O	Other	###	40	(	(	(	(	_	41	punct	_	_
Fig	NN	B-NP	B-protein	Other	###	41	Fig	Fig	NN	NN	_	34	dep	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	41	punct	_	_
3	CD	I-NP	I-protein	Other	###	43	3	3	CD	CD	_	41	nummod	_	_
)	)	O	O	Other	###	44	)	)	)	)	_	41	punct	_	_
.	.	O	O	Other	###	45	.	.	.	.	_	9	punct	_	_

To	TO	B-VP	O	Other	###	1	To	To	TO	TO	_	2	mark	_	_
evaluate	VB	I-VP	O	Other	###	2	evaluate	evaluate	VB	VB	_	18	advcl	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	4	det	_	_
possibility	NN	I-NP	O	Other	###	4	possibility	possibility	NN	NN	_	2	dobj	_	_
of	IN	B-PP	O	Other	###	5	of	of	IN	IN	_	9	case	_	_
non	JJ	B-NP	O	Other	###	6	non	non	JJ	JJ	_	9	amod	_	_
-	-	O	O	Other	###	7	-	-	-	-	_	6	punct	_	_
specific	JJ	B-NP	O	Other	###	8	specific	specific	JJ	JJ	_	6	dep	_	_
inhibition	NN	I-NP	O	Other	###	9	inhibition	inhibition	NN	NN	_	4	nmod	_	_
by	IN	B-PP	O	Other	###	10	by	by	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	12	det	_	_
drug	NN	I-NP	O	Other	###	12	drug	drug	NN	NN	_	9	nmod	_	_
at	IN	B-PP	O	Other	###	13	at	at	IN	IN	_	15	case	_	_
high	JJ	B-NP	O	Other	###	14	high	high	JJ	JJ	_	15	amod	_	_
concentrations	NNS	I-NP	O	Other	###	15	concentrations	concentrations	NNS	NNS	_	9	nmod	_	_
,	,	O	O	Other	###	16	,	,	,	,	_	18	punct	_	_
we	PRP	B-NP	O	Other	###	17	we	we	PRP	PRP	_	18	nsubj	_	_
observed	VBD	B-VP	O	Other	###	18	observed	observed	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	21	det	_	_
dose	NN	I-NP	O	Other	###	20	dose	dose	NN	NN	_	21	compound	_	_
response	NN	I-NP	O	Other	###	21	response	response	NN	NN	_	18	dobj	_	_
of	IN	B-PP	O	Other	###	22	of	of	IN	IN	_	23	case	_	_
PDTC	NN	B-NP	O	Other	###	23	PDTC	PDTC	NN	NN	_	21	nmod	_	_
and	CC	I-NP	O	Other	###	24	and	and	CC	CC	_	23	cc	_	_
LY294002	NN	I-NP	O	Other	###	25	LY294002	LY294002	NN	NN	_	23	conj	_	_
for	IN	B-PP	O	Other	###	26	for	for	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	27	the	the	DT	DT	_	28	det	_	_
inhibition	NN	I-NP	O	Other	###	28	inhibition	inhibition	NN	NN	_	21	nmod	_	_
of	IN	B-PP	O	Other	###	29	of	of	IN	IN	_	31	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	30	IL-17	IL-17	NN	NN	_	31	compound	_	_
production	NN	I-NP	O	Other	###	31	production	production	NN	NN	_	28	nmod	_	_
in	IN	B-PP	O	Other	###	32	in	in	IN	IN	_	33	case	_	_
PBMC	NN	B-NP	B-cell_type	Other	###	33	PBMC	PBMC	NN	NN	_	31	nmod	_	_
.	.	O	O	Other	###	34	.	.	.	.	_	18	punct	_	_

There	EX	B-NP	O	Other	###	1	There	There	EX	EX	_	2	expl	_	_
were	VBD	B-VP	O	Other	###	2	were	were	VBD	VBD	_	0	root	_	_
dose	JJ	B-NP	O	Other	###	3	dose	dose	JJ	JJ	_	6	amod	_	_
-	-	O	O	Other	###	4	-	-	-	-	_	3	punct	_	_
dependent	JJ	B-NP	O	Other	###	5	dependent	dependent	JJ	JJ	_	3	dep	_	_
inhibitions	NNS	I-NP	O	Other	###	6	inhibitions	inhibitions	NNS	NNS	_	2	nsubj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	9	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	8	IL-17	IL-17	NN	NN	_	9	compound	_	_
production	NN	I-NP	O	Other	###	9	production	production	NN	NN	_	6	nmod	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	12	case	_	_
chemical	JJ	B-NP	O	Other	###	11	chemical	chemical	JJ	JJ	_	12	amod	_	_
inhibitors	NNS	I-NP	O	Other	###	12	inhibitors	inhibitors	NNS	NNS	_	9	nmod	_	_
(	(	O	O	Other	###	13	(	(	(	(	_	14	punct	_	_
Fig	NN	B-NP	O	Other	###	14	Fig	Fig	NN	NN	_	12	appos	_	_
.	.	O	O	Other	###	15	.	.	.	.	_	14	punct	_	_
4a	NN	I-NP	O	Other	###	16	4a	4a	NN	NN	_	14	dep	_	_
)	)	O	O	Other	###	17	)	)	)	)	_	14	punct	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	2	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	3	det	_	_
other	JJ	I-NP	O	Other	###	2	other	other	JJ	JJ	_	3	amod	_	_
inhibitors	NNS	I-NP	O	Other	###	3	inhibitors	inhibitors	NNS	NNS	_	10	nsubj	_	_
in	IN	B-PP	O	Other	###	4	in	in	IN	IN	_	5	case	_	_
addition	NN	B-NP	O	Other	###	5	addition	addition	NN	NN	_	3	nmod	_	_
to	TO	B-PP	O	Other	###	6	to	to	TO	TO	_	7	case	_	_
PDTC	NN	B-NP	O	Other	###	7	PDTC	PDTC	NN	NN	_	5	nmod	_	_
and	CC	I-NP	O	Other	###	8	and	and	CC	CC	_	7	cc	_	_
LY294002	NN	I-NP	O	Other	###	9	LY294002	LY294002	NN	NN	_	7	conj	_	_
showed	VBD	B-VP	O	Other	###	10	showed	showed	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	13	det	_	_
same	JJ	I-NP	O	Other	###	12	same	same	JJ	JJ	_	13	amod	_	_
pattern	NN	I-NP	O	Other	###	13	pattern	pattern	NN	NN	_	10	dobj	_	_
of	IN	B-PP	O	Other	###	14	of	of	IN	IN	_	15	case	_	_
inhibition	NN	B-NP	O	Other	###	15	inhibition	inhibition	NN	NN	_	13	nmod	_	_
.	.	O	O	Other	###	16	.	.	.	.	_	10	punct	_	_

Cytotoxic	JJ	B-NP	O	Other	###	1	Cytotoxic	Cytotoxic	JJ	JJ	_	2	amod	_	_
effects	NNS	I-NP	O	Other	###	2	effects	effects	NNS	NNS	_	14	nsubjpass	_	_
on	IN	B-PP	O	Other	###	3	on	on	IN	IN	_	4	case	_	_
PBMC	NN	B-NP	B-cell_type	Other	###	4	PBMC	PBMC	NN	NN	_	2	nmod	_	_
by	IN	B-PP	O	Other	###	5	by	by	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	8	det	_	_
chemical	JJ	I-NP	O	Other	###	7	chemical	chemical	JJ	JJ	_	8	amod	_	_
inhibitors	NNS	I-NP	O	Other	###	8	inhibitors	inhibitors	NNS	NNS	_	2	nmod	_	_
at	IN	B-PP	O	Other	###	9	at	at	IN	IN	_	11	case	_	_
experimental	JJ	B-NP	O	Other	###	10	experimental	experimental	JJ	JJ	_	11	amod	_	_
concentrations	NNS	I-NP	O	Other	###	11	concentrations	concentrations	NNS	NNS	_	8	nmod	_	_
were	VBD	B-VP	O	Other	###	12	were	were	VBD	VBD	_	14	auxpass	_	_
not	RB	I-VP	O	Other	###	13	not	not	RB	RB	_	14	neg	_	_
observed	VBN	I-VP	O	Other	###	14	observed	observed	VBN	VBN	_	0	root	_	_
(	(	O	O	Other	###	15	(	(	(	(	_	18	punct	_	_
Fig	NNP	B-NP	O	Other	###	16	Fig	Fig	NNP	NNP	_	18	compound	_	_
.	.	O	O	Other	###	17	.	.	.	.	_	18	punct	_	_
4b	NNP	I-NP	O	Other	###	18	4b	4b	NNP	NNP	_	14	dep	_	_
)	)	O	O	Other	###	19	)	)	)	)	_	18	punct	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	14	punct	_	_

